Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxide-induced oxidative stress

Journal of Dermatological Science

Volumn 58, Issue 3, 2010, Pages 204-210

  Li, Ji ^a,b   Peng, Lefang ^a   Wu, Lisha ^a,b   Kuang, Yehong ^a,b   Su, Juan ^a,b   Yi, Mei ^a   Hu, Xinglin ^a   Li, Dai ^a,b   Xie, Hongfu ^a   Kanekura, Takuro ^c   Chen, Xiang ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

CD147; Hydrogen peroxide; Melanoma; Oxidative stress

Indexed keywords

CD147 ANTIGEN; HYDROGEN PEROXIDE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER MORPHOLOGY; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SENSITIZATION;

ANTIGENS, CD147; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; HYDROGEN PEROXIDE; MALONDIALDEHYDE; MELANOMA; OXIDANTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SKIN NEOPLASMS; SUPEROXIDE DISMUTASE;

EID: 77953135652     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2010.03.022     Document Type: Article

References (43)

1. Conklin K.A. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004, 3:294-300.
2. Lamson D.W., Brignall M.S. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altern Med Rev 1999, 4:304-329.
3. Afonso V., Champy R., Mitrovic D., Collin P., Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine 2007, 74:324-329.
4. Renschler M.F. The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer 2004, 40:1934-1940.
5. Kovacic P. Unifying mechanism for anticancer agents involving electron transfer and oxidative stress: clinical implications. Med Hypotheses 2007, 69:510-516.
6. Perlis C., Herlyn M. Recent advances in melanoma biology. Oncologist 2004, 9:182-187.
7. Atkins M.B. Cytokine-based therapy and biochemotherapy for advanced melanoma. Clin Cancer Res 2006, 12. 2353-2358s.
8. Wittgen H.G., van Kempen L.C. Reactive oxygen species in melanoma and its therapeutic implications. Melanoma Res 2007, 17:400-409.
9. Sander C.S., Chang H., Hamm F., Elsner P., Thiele J.J. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int J Dermatol 2004, 43:326-335.
10. Baldi A., Lombardi D., Russo P., Palescandolo E., De Luca A., Santini D., et al. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress. Clin Cancer Res 2005, 11:3175-3183.
11. Frank J., Lornejad-Schäfer M.R., Schöffl H., Flaccus A., Lambert C., Biesalski H.K. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy. Int J Oncol 2007, 31:1539-1545.
12. Miyauchi T., Kanekura T., Yamaoka A., Ozawa M., Miyazawa S., Muramatsu T. Basigin, a new, broadly distributed member of the immunoglobulin superfamily, has strong homology with both the immunoglobulin V domain and the H-chain of major histocompatibility complex class II antigen. J Biochem 1990, 107:316-323.
13. Kanekura T., Miyauchi T., Tashiro M., Muramatsu T. Basigin, a new member of the immunoglobulin superfamily: genes in different mammalian species, glycosylation changes in the molecule from adult organs and possible variation in the N-terminal sequences. Cell Struct Funct 1991, 16:23-30.
14. Chen X., Lin J., Kanekura T., Su J., Lin W., Xie H., et al. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma. Cancer Res 2006, 66:11323-11330.
15. Su J., Chen X., Kanekura T. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis. Cancer Lett 2009, 273:140-147.
16. Kuang Y.H., Chen X., Su J., Wu L.S., Li J., Chang J., et al. Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing. J Proteome Res 2008, 7:4784-4791.
17. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 1984, 226:544-547.
18. Seko Y., Fujimura T., Taka H., Mineki R., Murayama K., Nagai R. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun 2004, 317:162-168.
19. Doyle V., Virji S., Crompton M. Evidence that cyclophilin-A protects cells against oxidative stress. Biochem J 1999, 341:127-132.
20. Hong F., Lee J., Song J.W., Lee S.J., Ahn H., Cho J.J., et al. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. FASEB J 2002, 16:1633-1635.
21. Ghezzi P., Casagrande S., Massignan T., Basso M., Bellacchio E., Mollica L., et al. Redox regulation of cyclophilin A by glutathionylation. Proteomics 2006, 6:817-825.
22. Yurchenko V., Zybarth G., O'Connor M., Dai W.W., Franchin G., Hao T., et al. Active site residues of cyclophilin A are crucial for its signaling activity via CD147. J Biol Chem 2002, 277:22959-22965.
23. Boulos S., Meloni B.P., Arthur P.G., Majda B., Bojarski C., Knuckey N.W. Evidence that intracellular cyclophilin A and cyclophilin A/CD147 receptor-mediated ERK1/2 signalling can protect neurons against in vitro oxidative and ischemic injury. Neurobiol Dis 2007, 25:54-64.
24. Satoh T., Sakai N., Enokido Y., Uchiyama Y., Hatanaka H. Free radical-independent protection by nerve growth factor and Bcl-2 of PC12 cells from hydrogen peroxide-triggered apoptosis. J Biochem (Tokyo) 1996, 120:540-546.
25. Zhou Y., Wang Q., Mark Evers B., Chung D.H. Oxidative stress-induced intestinal epithelial cell apoptosis is mediated by p38 MAPK. Biochem Biophys Res Commun 2006, 350:860-865.
26. Deng M., Zhao J.Y., Ju X.D., Tu P.F., Jiang Y., Li Z.B. Protective effect of tubuloside B on TNFalpha-induced apoptosis in neuronal cells. Acta Pharmacol Sin 2004, 25:1276-1284.
27. Chan E.L., Murphy J.T. Reactive oxygen species mediate endotoxin-induced human dermal endothelial NF-kappaB activation. J Surg Res 2003, 111:120-126.
28. Knudson C.M., Brown N.M. Mitochondria potential, bax " activation," and programmed cell death. Methods Mol Biol 2008, 414:95-108.
29. Pelicano H., Carney D., Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004, 7:97-110.
30. Mates J.M., Sanchez-Jimenez F.M. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol 2000, 132:157-170.
31. Kong Q., Beel J.A., Lillehei K.O. A threshold concept for cancer therapy. Med Hypotheses 2000, 55:29-35.
32. Kovacic P., Osuna J.A. Mechanisms of anti-cancer agents: emphasis on oxidative stress and electron transfer. Curr Pharmaceut Des 2000, 6:277-309.
33. Bowling B.D., Doudican N., Manga P., Orlow S.J. Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother Pharmacol 2008, 63:37-43.
34. Symons M.C., Rusakiewicz S., Rees R.C., Ahmad S.I. Hydrogen peroxide: a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours. Med Hypotheses 2001, 57:56-58.
35. Chen X., Kanekura T., Kanzaki T. Expression of Basigin in human fetal, infantile and adult skin and in basal cell carcinoma. J Cutan Pathol 2001, 28:184-190.
36. Chen X., Su J., Chang J., Kanekura T., Li J., Kuang Y.H., et al. Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line. Cancer Invest 2008, 26:689-697.
37. Crow M.T., Mani K., Nam Y.J., Kitsis R.N. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 2004, 95:957-970.
38. Shackelford R.E., Kaufmann W.K., Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic Biol Med 2000, 28:1387-1404.
39. Kuang Y.H., Chen X., Su J., Wu L.S., Liao L.Q., Li D., et al. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion. Cancer Lett 2009, 276:189-195.
40. Intasai N., Mai S., Kasinrerk W., Tayapiwatana C. Binding of multivalent CD147 phage induces apoptosis of U937 cells. Int Immunol 2006, 18:1159-1169.
41. Yang J.M., O'Neill P., Jin W., Foty R., Medina D.J., Xu Z., et al. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J Biol Chem 2006, 281:9719-9727.
42. Kim Y.S., Han S. Nitric oxide protects Cu, Zn-superoxide dismutase from hydrogen peroxide-induced inactivation. FEBS Lett 2000, 479:25-28.
43. Purucker E., Winograd R., Roeb E., Matern S. Glutathione status in liver and plasma during development of biliary cirrhosis after bile duct ligation. Res Exp Med (Berl) 1998, 198:167-174.